biotechnology
Lonza to establish China base through GE Healthcare partnership
Biotechnology company Lonza has announced an initiative with GE Healthcare in which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou, China (CN). Read more
Clinical collaboration announced for window of opportunity study into breast cancer
Biotechnology company, Oncolytics Biotech, has announced a clinical collaboration with an academic research group dedicated to clinical and translational research in breast cancer, SOLTI. Read more
Companies file for a new manufacturing facility for non-opioid injectable radiopharmaceutical, Sr89
Commercial stage biotechnology acceleration development company, Q BioMed, with licensor of Strontium 89 Chloride, BioNucleonics, have announced the submission of a supplemental regulatory filing for a new manufacturing facility. Read more
Biotech enters multi-year R&D collaboration with Pfizer
Biotechnology company, BioNTech, has entered into a multi-year research and development (R&D) collaboration with Pfizer for the development of mRNA-based vaccines for the prevention of influenza (flu). Read more
Sygnature Discovery announces next stage of expansion with new facility at Alderley Park
Independent provider of integrated drug discovery and pre-clinical services and expertise, Sygnature Discovery, has announced the next stage of its expansion plans with the addition of a new facility at Alderley Park. Read more
Biotech shows positive results from extension study into universal RSV vaccine
Biotechnology company, Bavarian Nordic, has revealed positive data from the extension study of its Phase II study investigating its universal respiratory syncytial virus (RSV) vaccine, MVA-BN RSV, in older adults. Read more
Biotech receives Innovate UK funding to support development of intravenous antibiotic project
Biotechnology company, Phico Therapeutics, has been awarded significant funding from Innovate UK to support the manufacturing development of its intravenous antibiotic, SASPject PT3.8. Read more
Biotech and university extend option agreement for novel biomarker for monitoring glaucoma
Commercial stage biotechnology acceleration development company, Q BioMed, has extended its option agreement with Washington University in St Louis for a novel companion biomarker for monitoring glaucoma and initiation of a clinical study. Read more
Biotech receives grant in support of ongoing research into novel antibody platform
Biotechnology company focused on the discovery and optimisation of fully human antibodies, IONTAS, has been awarded a major grant to support ongoing research into its novel antibody platform, KnotBody. Read more
Biotech receives grant from Innovate UK to progress its universal flu vaccine programme
Emergex Vaccines Holding (Emergex) — a biotechnology company — has been awarded with a grant of £979,318 from Innovate UK to progress its universal flu vaccine programme through preclinical development. Read more
Exclusive licensing agreement announced for production of recombinant proteins
Producer of tailor-made recombinant glycoproteins and gene therapy vectors, CEVEC Pharmaceuticals, and global biotechnology company, CSL, have announced an exclusive licensing agreement to produce a recombinant C1 Esterase Inhibitor. Read more
Genmab receives approval for its treatment for newly diagnosed multiple myeloma
Biotechnology company, Genmab, has announced that the FDA has approved the use of DARZALEX (daratumumab) in combination with bortezomib, melphalan and prednisone (VMP) for the treatment of patients with newly diagnos Read more
Partnership sees launch of mobile platform for lentivirus testing
Biotechnology company, Takara Bio USA (TBUSA), has teamed up with smartphone diagnostics specialists, Novarum, to develop an integrated, mobile platform which detects and quantifies recombinant lentivirus in packaging cell supernatants. Read more
Orchard Therapeutics opens new US office
Orchard Therapeutics, a commercial and clinical-stage company, has opened a new US office located in Boston’s Seaport District, building upon the company’s footprint in London as well as Foster City and Menlo Park, California. Read more
ADC Bio secures funding for US expansion and development of new bioconjugation method
Innovative biotechnology company, ADC Biotechnology, has secured £1.14 million in funding from Downing LLP to assist the company in its US expansion and aid in the development of an advanced bioconjugation method. Read more
Sartorius and Penn State partner to advance biotech teaching and research
A collaborative partnership has been entered into by Sartorius Stedim Biotech and Penn State University for the advancement of multidisciplinary teaching and research in biotechnology. Read more
Biotech and pharma company sign licence agreement in field of veterinary diagnostics
Biotechnology company, Leukocare, and pharma company, Boehringer Ingelheim, have entered into a licence agreement in the field of veterinary diagnostics. Read more
Shire collaborates with NIBRT for professional training development
Biotechnology company, Shire, has announced a professional training development collaboration with the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland. Read more
Q BioMed files for FDA approval of non-opioid manufacturing facility
Commercial stage biotechnology acceleration development company, Q BioMed, and Bio-Nucleonics, licensor of Strontium-89 Chloride, have filed for regulatory approval of a new manufacturing facility by the US Food and Drug Administration (FDA). Read more
FDA accepts IND application for UK biotech’s antibacterial drug candidate
Clinical stage biotechnology company, Destiny Pharma, has announced that the US Food and Drug Administration (FDA) has accepted its investigational new drug application (IND) for its lead clinical drug candidate, XF-73. Read more
